Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|May 1, 2007
- Volume 0 0
MYLAN BARRED FROM SELLING GENERIC TOPAMAX
Advertisement
A federal judge in NewJersey issued an injunctionpermanently barringMylan Pharmaceuticalsfrom selling generic topiramatetablets and capsulesin the United Statesbefore September 26,2008, the expiration dateof the patent for TOPAMAX(topiramate) heldby Ortho-McNeil NeurologicsInc. Mylan hadchallenged the validity ofthat patent and filed anabbreviated new drugapplication to market ageneric version of theepilepsy drug. The brandedmanufacturer counteredwith a patentinfringement complaintagainst Mylan and obtaineda preliminary injunctionagainst the genericfirm last fall.
Articles in this issue
over 19 years ago
can you READ these Rxs?over 19 years ago
compounding HOTLINEover 19 years ago
Pseudoephedrine Logs Need Constant Tendingover 19 years ago
Another Federal Court Rejects a Drug Importation Planover 19 years ago
Home Infusion Therapy Gets Patients Out of the Hospitalover 19 years ago
RESPy AWARD: Teamwork Is the Thread That Bindsover 19 years ago
Child-resistant Does Not Mean Childproofover 19 years ago
ccpa SPEAKS OUT: CCPA Works to Improve Medicare Part Dover 19 years ago
Genetic Testing: Remarkable Resource or Invasion of Privacy?over 19 years ago
case STUDIESAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ramantamig's 93.6% ORR and Outpatient CRS Control
2
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
3
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
4
After 180 Years, Multiple Myeloma Gets a Definition of Cure
5